Showing results (931-940 of 1,019) with videos related to
Sort By:
Pageof 102
Clinicoeconomics and Outcomes Research : CEOR|May 8, 2026
Semaglutide 2.4 mg for Obese Patients with MASH: A Cost-Effectiveness Analysis from the Italian NHS PerspectiveEnrico Torre, Sergio Di Matteo, Chiara Martinotti, et al.Clinicoeconomics and Outcomes Research : CEOR|May 12, 2026
Cost-Effectiveness of Chondroitin Sulphate (with or without Glucosamine) Prescription in the Treatment of Knee Osteoarthritis Compared to NSAIDs and COXIBsCarlos Rubio-Terrés, Miguel Bernad Pineda, Josep VergésClinicoeconomics and Outcomes Research : CEOR|April 30, 2026
Assessment of the Lifetime Costs of Severe Visual Impairment Due to Retinitis PigmentosaDejan Milentijevic, Christine Ferro, Sara Rosenblum, et al.Clinicoeconomics and Outcomes Research : CEOR|May 13, 2026
Research Gaps and Priorities for aHUS in the Gulf Cooperation Countries (GCC): Findings from a Payer-Focused Expert MeetingLaila Carolina Abu Esba, Ghada Hussain AlMardawi, Abdulaziz Alhenaidi, et al.Clinicoeconomics and Outcomes Research : CEOR|February 26, 2026
Impact of Delaying Disease Recurrence on Economic Burden in Patients with HER2+ Early-Stage Breast Cancer (eBC)Nicole Princic, Eleanor Faherty, Meghan Moynihan, et al.Clinicoeconomics and Outcomes Research : CEOR|May 31, 2014
Health economics evidence for medical nutrition: are these interventions value for money in integrated care?Stefan Walzer, Daniel Droeschel, Mark Nuijten, et al.Clinicoeconomics and Outcomes Research : CEOR|February 24, 2023
CELESTIA: Cost-Effectiveness Analysis of Empagliflozin Versus Sitagliptin in Patients with Type 2 Diabetes in GreeceGianni Ghetti, Lorenzo Pradelli, Giannis Papageorgiou, et al.Clinicoeconomics and Outcomes Research : CEOR|October 28, 2016
Methods to construct a step-by-step beginner's guide to decision analytic cost-effectiveness modelingTamlyn Rautenberg, Claire Hulme, Richard EdlinClinicoeconomics and Outcomes Research : CEOR|October 28, 2016
Cost-effectiveness of eplerenone in NYHA class II chronic heart failure patients with reduced LVEF: an analysis for GreeceKostas Athanasakis, Aikaterini Bilitou, Dawn Lee, et al.Clinicoeconomics and Outcomes Research : CEOR|January 6, 2017
Real-world medication persistence and outcomes associated with basal insulin and glucagon-like peptide 1 receptor agonist free-dose combination therapy in patients with type 2 diabetes in the USJay Lin, Melissa Lingohr-Smith, Tao FanPageof 102